Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016).
Saved in:
| Title: | Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016). |
|---|---|
| Authors: | Xu, Peng1 (AUTHOR), Luo, Wen1 (AUTHOR) 710434705@qq.com, Hu, Jingjing2 (AUTHOR), Ma, Xiaobin1 (AUTHOR), Hao, Qian1 (AUTHOR), Hui, Wentao1 (AUTHOR), Zhou, Zhangjian1 (AUTHOR), Lin, Shuai1 (AUTHOR), Wang, Meng1 (AUTHOR), Wu, Hao3 (AUTHOR) lfshwu@xjtu.edu.cn, Dai, Zhijun4 (AUTHOR) dzj0911@126.com, Kang, Huafeng1 (AUTHOR) kanghuafeng1973@126.com |
| Source: | Cancer Medicine. Jun2024, Vol. 13 Issue 11, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.7244 |
